Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check3 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page version. This update reflects a minor metadata change rather than a modification to study details, locations, or eligibility criteria.SummaryDifference0.0%

- Check10 days agoChange DetectedThree auxiliary sections labeled Description Related Info, AbbVie, and Helpful Links Provided by were removed, reducing footer/navigation clutter without altering the primary study details.SummaryDifference0.1%

- Check17 days agoChange DetectedThe entry for Malmö, Skåne County, Sweden, 214 28 replaces Malmo with the proper diacritic in the city name.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page now displays Revision: v3.5.3 instead of Revision: v3.5.2. This indicates a minor site update that does not alter the study details or eligibility information.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page’s revision label was updated from v3.5.0 to v3.5.2. No study details were changed.SummaryDifference0.0%

- Check38 days agoChange DetectedThe location entries were updated to include 'State of Vienna' as the state designation and 'Vienna, State of Vienna, Austria, 1100' as a new location, replacing the previous 'Vienna' and 'Vienna, Vienna, Austria, 1100' entries.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.